ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2215–38.22Address for reprints: a single reprint of this document is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. This document (reprint no. 71-0205), as well as the companion full-text guideline (reprint no. 71-0206), are available on the ACC Web site at www.acc.organd the AHA Web site at http://www.americanheart.org. To purchase additional reprints (specify version): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.
Authors
Discussion
Loading...
Member takes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“These guidelines have applications—and implications—far beyond the practice of interventional cardiology. It's imperative that physicians and hospital administrators carefully review the guidelines, because they may be used to grade performance.”
“The science shows that patients truly benefit from a 'door-to-balloon time' of 90 minutes or less. We have consistently looked at where the science says we should be, and challenged ourselves.”
TFTed FeldmanProfessor of medicine, Northwestern University Medical School
“The use of drug-eluting stents is rapidly changing the treatment of coronary artery disease. These guidelines address the real-world issues that are important to the use of drug-eluting stents.”
Cite This Study
Smith et al. (2001) studied this question.